Advertisement

U.S. markets closed

S&P Futures
4,146.50
+4.75(+0.11%)
Dow Futures
32,841.00
+49.00(+0.15%)
Nasdaq Futures
13,195.50
+12.25(+0.09%)
Russell 2000 Futures
1,943.60
+2.50(+0.13%)
Crude Oil
90.25
-0.51(-0.56%)
Gold
1,801.30
-3.90(-0.22%)

Advertisement

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

7.01

+0.21

(+3.09%)

At close: 04:00PM EDT

6.90

-0.11

(-1.57%)

After hours:

07:17PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Double Moving Average Crossover

View all chart patterns

Performance Outlook

Previous Close	6.80
Open	6.82
Bid	6.89 x 1300
Ask	6.90 x 800
Day's Range	6.79 - 7.13
52 Week Range	3.66 - 11.82
Volume	507,574
Avg. Volume	541,103

Market Cap	236.805M
Beta (5Y Monthly)	-1.00
PE Ratio (TTM)	5.15
EPS (TTM)	1.36
Earnings Date	Aug 11, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	18.33

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

124% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CODX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Co-Diagnostics, Inc.
Analyst Report: Becton, Dickinson and CompanyBecton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Rating
Fair Value
Economic Moat
5 days agoMorningstar

All

Simply Wall St.
Co-Diagnostics, Inc.'s (NASDAQ:CODX) Stock Is Going Strong: Is the Market Following Fundamentals?
Co-Diagnostics (NASDAQ:CODX) has had a great run on the share market with its stock up by a significant 59% over the...
- Skyline Champion Corporation's (NYSE:SKY) Stock Is Going Strong: Is the Market Following Fundamentals?
  Simply Wall St.
- Farmland Partners Inc. (NYSE:FPI) Stock's On A Decline: Are Poor Fundamentals The Cause?
  Simply Wall St.
PR Newswire
Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in Chicago
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be attending and speaking at the Yale School of Public Health SalivaDirect™ Conference held July 28-29 in Chicago, Il.
PR Newswire
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems (BMS) at the Company's customer and distributor update today at AACC.